Essential thread by Holger Hestermeyer on Trump’s failed attempt to put America first in acquiring a Coronavirus vaccine exclusively for the United States.
First published in March 2020.
Trump’s attempt to take over Curevac, a company developing a Coronavirus vaccine, to procure the vaccine exclusively for the United States seems to have failed.
Trump kassiert Korb im Kampf um Impfstoffhersteller. / Frankfurter Allgemeine
Or to put it bluntly: he’s not after the money.
His words: “If we manage to find a vaccine, this is not just for a region. We want to help people in the whole world!”
But there’s more to the story: behind Curevac you will find one of the coolest initiatives ever: the Coalition for Epidemic Preparedness Innovations (CEPI).
CEPI is a public private partnership to develop vaccines. Because IP incentives such as patents did not manage to get the trick done.
Curevac and CEPI contracted to specifically cooperate on a Coronavirus vaccine with CEPI providing funding (an amount that now looks ridiculous).
CureVac and CEPI extend their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019. / Curevac
I do not have access to the contracts involved, but I assume – given the CEPI stakeholders – that they provide for adequate public access.
If, however, there is a fear that the contractual constructs used do not insure adequate worldwide public access to the vaccine (should you be successful) – dear Ingmar Hoerr – and you want some academic lawyers to help: Ready to do so and find the right people.
And just in case you were wondering: Moderna – that US company on the verge of finding a Coronavirus vaccine?
Moderna’s Work on a Potential Vaccine Against COVID-19. / Moderna
Also CEPI funded.
Finally, the Coalition for Epidemic Preparedness Innovations just received another £20 million from the UK.
It also received €140 million from Germany.
As for CEPI’s financing:
Tweets posted on 15 March 2020 by @hhesterm.